KYMR
Kymera Therapeutics Inc

838
Mkt Cap
$7.46B
Volume
1.02M
52W High
$103.00
52W Low
$19.45
PE Ratio
-24.49
KYMR Fundamentals
Price
$90.10
Prev Close
$91.35
Open
$89.24
50D MA
$78.97
Beta
1.62
Avg. Volume
861,084.94
EPS (Annual)
-$3.69
P/B
4.64
Rev/Employee
$164,752.10
$5,808.19
Loading...
Loading...

About

Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of human diseases through the development of innovative, highly differentiated medicines. It focuses on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation system. The company leverages targeted protein degradation (TPD) to develop medicines that address critical health challenges and have the potential to significantly improve patients lives. Its pipeline emphasizes oral small-molecule degraders, offering a new generation of convenient and highly effective therapies. The company was founded by Bruce Lee Booth and Nello Mainolfi on September 29, 2015 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
238

Frequently Asked Questions

What is Market Cap of Kymera Therapeutics Inc?
What is the 52-week high for Kymera Therapeutics Inc?
What is the 52-week low for Kymera Therapeutics Inc?
What is Kymera Therapeutics Inc stock price today?
What was Kymera Therapeutics Inc stock price yesterday?
What is the PE ratio of Kymera Therapeutics Inc?
What is the Price-to-Book ratio of Kymera Therapeutics Inc?
What is the 50-day moving average of Kymera Therapeutics Inc?
How many employees does Kymera Therapeutics Inc have?

Latest KYMR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.